The National Association of Medicaid Directors sent a letter to the leaders of the House Energy and Commerce Committee regarding the impact to the Medicaid program from federal legislative efforts to incentivize and expedite high-cost cure-like pharmaceutical treatments and devices.
- This week the NAMD newsletter welcomes new directors and covers LTSS, national health expenditures, Hill news on CHIP and tax reform, value based purchasing and Medicaid leadership. December 12, 2017
- In the newsletter we cover Opioids, Access Rule guidance, Medicare Part D, NASBO expenditure report and state job opportunities. November 28, 2017
- NAMD newsletter covers our Fall Conference; 1115 waivers; CHIP; Opioids; and State job openings. November 14, 2017